首页> 外文期刊>Pharmaceutical research >Cisplatin-loaded polymer-metal complex micelle with time-modulated decaying property as a novel drug delivery system.
【24h】

Cisplatin-loaded polymer-metal complex micelle with time-modulated decaying property as a novel drug delivery system.

机译:具有顺时针衰减特性的顺铂负载的聚合物-金属复合胶束作为新型药物递送系统。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: The pharmacological activity and pharmacokinetics of cisplatin (CDDP)-loaded polymeric micelles were examined to reveal their usefulness as a novel tumor-directed drug carrier system of CDDP. METHODS: In biodistribution assay, free CDDP or CDDP-loaded micelles were administered intravenously to Lewis lung carcinoma-bearing mice. Antitumor activity and nephrotoxicity were respectively evaluated by the measurement of tumor size and plasma blood urea nitrogen (BUN) after single bolus i.v. administration of each drug. RESULTS: The time profile of the plasma Pt level after the injection of the micelles exhibited a time-modulated disappearance as observed in saline in vitro. The micelles exhibited 5.2- and 4.6-fold higher AUC of Pt in the plasma and tumor, respectively, with minimal change in the kidney, in comparison with free CDDP, suggesting that prolonged circulation of Pt in circulation and specific accumulation in the tumor were achieved utilizing the micellar drug carrier system. Administration of the micelles at the dose exhibiting antitumor activity similar to free CDDP did not increase the plasma BUN, whereas free CDDP induced its remarkable increase. CONCLUSION: CDDP-loaded micelles restrained nephrotoxicity, which is the dose-limiting factor of CDDP, while exhibiting tumor-specific accumulation. Thus, CDDP-loaded micelles are expected to be a novel formulation of CDDP for clinical use.
机译:目的:检查了载有顺铂(CDDP)的聚合物微团的药理活性和药代动力学,以揭示其作为新型的CDDP肿瘤定向药物载体系统的有用性。方法:在生物分布测定中,向患有Lewis肺癌的小鼠静脉内施用游离CDDP或CDDP负载胶束。单次静脉推注后,通过测量肿瘤大小和血浆尿素氮(BUN)分别评估其抗肿瘤活性和肾毒性。每种药物的给药。结果:注射胶束后血浆Pt水平的时间曲线显示出时间调节的消失,如在体外盐水中观察到的。与游离CDDP相比,胶束在血浆和肿瘤中分别表现出Pt的AUC高5.2倍和4.6倍,肾脏变化最小,这表明Pt在血液中的循环延长和在肿瘤中的特异性蓄积得以实现利用胶束药物载体系统。以与游离CDDP相似的抗肿瘤活性的剂量施用胶束不会增加血浆BUN,而游离CDDP诱导其显着增加。结论:载有CDDP的胶束抑制肾毒性,这是CDDP的剂量限制因子,同时表现出肿瘤特异性的积累。因此,预期载有CDDP的胶束是用于临床的CDDP的新制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号